Postmenopausal osteoporosis (PMO) is linked to estrogen deficiency and immune dysregulation. The balance between pro- and anti-inflammatory cytokines may be critical in bone loss pathogenesis. Objective: To evaluate serum IL(6,-β, and 10) levels and their ratios in elderly Iraqi postmenopausal women with osteoporosis compared to controls. Methods: A cross-sectional case-control study enrolled 160 postmenopausal women (80 osteoporotic, 80 controls) at Baghdad Teaching Hospital. Serum IL(6,-β, and 10) were measured by ELISA. Bone mineral density (BMD) was assessed by DXA. Correlations between cytokines and BMD were analyzed. Results: Osteoporotic women had significantly higher IL-6 (9.80 ± 3.29 vs. 4.18 ± 1.55 pg/mL; p < 0.001) and IL-1β (6.93 ± 1.95 vs. 2.46 ± 1.20 pg/mL; p < 0.001), and lower IL-10 (3.14 ± 0.99 vs. 5.69 ± 1.36 pg/mL; p < 0.001). Cytokine ratios were markedly elevated in osteoporosis: IL-6/IL-10 (2.99 ± 0.90 vs. 0.78 ± 0.40), IL-1β/IL-10 (2.42 ± 0.79 vs. 0.48 ± 0.28), and (IL-6+IL-1β)/IL-10 (5.16 ± 1.54 vs. 1.32 ± 0.49; p < 0.001 for all). The IL-6/IL-10 ratio showed the highest diagnostic accuracy (AUC = 0.934). Vitamin D and estradiol were significantly lower in the osteoporosis group. Conclusion: Elderly Iraqi postmenopausal women with osteoporosis exhibit a pro-inflammatory immune profile with elevated IL-6 and IL-1β, reduced IL-10, and increased pro-inflammatory/anti-inflammatory ratios. The IL-6/IL-10 ratio may serve as practical biomarker for osteoporosis risk stratification.